九强生物: 关于公司获得发明专利证书的公告

Core Viewpoint - Beijing Jiukang Biotechnology Co., Ltd. has recently received four patent certificates from the National Intellectual Property Administration of the People's Republic of China, which will enhance the company's intellectual property advantages and promote technological innovation [1][2]. Patent Information - The patents include a novel variant of glucose-6-phosphate dehydrogenase with mutations D306C, D375C, and G426C, which results in a detection kit that is highly specific, sensitive, easy to operate, has a short detection time, and provides accurate quantification, suitable for high-throughput testing [1][2]. Impact on the Company - The acquisition of these patents is not expected to have a significant immediate impact on the company's production and operations, but it will strengthen the company's core competitiveness and establish a mechanism for continuous innovation [2].